Stay updated on Venetoclax and Lintuzumab-Ac225 in AML Patients Clinical Trial

Sign up to get notified when there's something new on the Venetoclax and Lintuzumab-Ac225 in AML Patients Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Venetoclax and Lintuzumab-Ac225 in AML Patients Clinical Trial page

  1. Check
    5 days ago
    No Change Detected
  2. Check
    12 days ago
    Change Detected
    Summary
    Revision v3.5.2 was added to the history and revision v3.5.0 was removed.
    Difference
    0.1%
    Check dated 2026-04-16T10:50:36.000Z thumbnail image
  3. Check
    19 days ago
    No Change Detected
  4. Check
    34 days ago
    Change Detected
    Summary
    Added Revision: v3.5.0 to the history and removed Revision: v3.4.3.
    Difference
    0.1%
    Check dated 2026-03-25T21:05:32.000Z thumbnail image
  5. Check
    48 days ago
    Change Detected
    Summary
    New revision entry v3.4.3 is added and v3.4.2 is removed from the study record history.
    Difference
    0.1%
    Check dated 2026-03-11T17:02:20.000Z thumbnail image
  6. Check
    77 days ago
    Change Detected
    Summary
    Revision: v3.4.2 was added to the history. Notices about government funding and operating status were removed.
    Difference
    0.8%
    Check dated 2026-02-11T02:07:35.000Z thumbnail image
  7. Check
    84 days ago
    Change Detected
    Summary
    A site-wide funding-status notice was added and the record history shows Revision v3.4.1, replacing Revision v3.4.0. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.8%
    Check dated 2026-02-03T23:52:46.000Z thumbnail image
  8. Check
    91 days ago
    Change Detected
    Summary
    UI updates include a new Show glossary option and explanations of the color-coded change highlights (green for additions and red for deletions) with a new revision tag (v3.4.0) visible on the page. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    1%
    Check dated 2026-01-27T23:41:29.000Z thumbnail image

Stay in the know with updates to Venetoclax and Lintuzumab-Ac225 in AML Patients Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Venetoclax and Lintuzumab-Ac225 in AML Patients Clinical Trial page.